Skip to search formSkip to main contentSkip to account menu

Cavinton

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThe pharmacokinetics of vinpocetine and its main metabolite, apovincaminic acid (AVA), were studied in the aged… 
1991
1991
The authors studied the efficacy of cavinton as an agent helpful in preventing neurologic disorders in the newborn with hypoxic… 
1990
1990
The hydroxyl radical scavenging capability of vinpocetine was studied in vitro by aromatic hydroxylation and deoxyribose… 
1986
1986
The authors studied the effect of cavinton (15-45 mg/day) and its combinations with different anticonvulsants on the time-course… 
1984
1984
The pharmacokinetics of vinpocetine after 10 mg po and iv doses was studied in six beagle dogs treated in cross-over design. The… 
1977
1977
Starting from (+) vincamine (I), simple derivatives of vincaminic acid (II), apovincaminic acid (V) and apovincaminol (VII) were… 
1976
1976
Systemic and cerebral haemodynamic effects of ethyl apovincaminate (RGH-4405, Cavinton), a new compound, have been investigated… 
1976
1976
The effect of ethyl apovincaminate (RGH-4405, Cavinton) on the rheoencephalogram and memory functions was studied in 50 patients… 
1976
1976
Some cerebrobiochemical effects of a new cerebrovasodilatory agent, ethyl apovincaminate (RGH-4405, Cavinton) have been studied…